中珠醫療(600568.SH)延期回覆上交所問詢函
格隆匯11月7日丨中珠醫療(600568.SH)公佈,公司於2019年10月31日收到上海證券交易所上市公司監管一部下發的《關於對中珠醫療控股股份有限公司終止部分募投項目並變更部分募集資金用途的問詢函》(上證公函【2019】2917號),(《問詢函》)。
公司收到《問詢函》後高度重視,立即組織相關各方根據《問詢函》的要求對所述問題進行逐項回覆。鑑於此次《問詢函》所涉及的部分問題尚需進一步核實並完善,且保薦機構出具意見尚須履行內部審核流程,無法在規定時間內完成回覆。為保證回覆內容的真實、準確、完整,保護全體股東合法權益,經向上海證券交易所申請,公司將延期回覆《問詢函》。
公司將積極協調相關方持續推進《問詢函》的回覆工作,預計於2019年11月15日前完成回覆工作,並按規定履行信息披露義務,敬請廣大投資者諒解。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.